Skip to main content

On the Discovery of TOR As the Target of Rapamycin.

Publication ,  Journal Article
Heitman, J
Published in: PLoS Pathog
2015

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

PLoS Pathog

DOI

EISSN

1553-7374

Publication Date

2015

Volume

11

Issue

11

Start / End Page

e1005245

Location

United States

Related Subject Headings

  • Virology
  • Transplants
  • TOR Serine-Threonine Kinases
  • Sirolimus
  • Immunosuppressive Agents
  • Humans
  • Anti-Bacterial Agents
  • Animals
  • 3207 Medical microbiology
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Heitman, J. (2015). On the Discovery of TOR As the Target of Rapamycin. PLoS Pathog, 11(11), e1005245. https://doi.org/10.1371/journal.ppat.1005245
Heitman, Joseph. “On the Discovery of TOR As the Target of Rapamycin.PLoS Pathog 11, no. 11 (2015): e1005245. https://doi.org/10.1371/journal.ppat.1005245.
Heitman J. On the Discovery of TOR As the Target of Rapamycin. PLoS Pathog. 2015;11(11):e1005245.
Heitman, Joseph. “On the Discovery of TOR As the Target of Rapamycin.PLoS Pathog, vol. 11, no. 11, 2015, p. e1005245. Pubmed, doi:10.1371/journal.ppat.1005245.
Heitman J. On the Discovery of TOR As the Target of Rapamycin. PLoS Pathog. 2015;11(11):e1005245.

Published In

PLoS Pathog

DOI

EISSN

1553-7374

Publication Date

2015

Volume

11

Issue

11

Start / End Page

e1005245

Location

United States

Related Subject Headings

  • Virology
  • Transplants
  • TOR Serine-Threonine Kinases
  • Sirolimus
  • Immunosuppressive Agents
  • Humans
  • Anti-Bacterial Agents
  • Animals
  • 3207 Medical microbiology
  • 3204 Immunology